Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
NVIDIA
NVDA
|
$11.7B |
| 2 |
Apple
AAPL
|
$2.4B |
| 3 |
Eaton
ETN
|
$1.08B |
| 4 |
Analog Devices
ADI
|
$927M |
| 5 |
Chipotle Mexican Grill
CMG
|
$893M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$1.76B |
| 2 |
Advanced Micro Devices
AMD
|
$1.21B |
| 3 |
Salesforce
CRM
|
$1.17B |
| 4 |
lululemon athletica
LULU
|
$996M |
| 5 |
Home Depot
HD
|
$936M |
Sector Composition
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Alcoa
AA
$8.01B
| $15.1M | 0.01% |
380,033
+233,580
| +159% | +$9.29M |
|
352
CAVA Group
CAVA
$7.6B
| $14.9M | 0.01% |
160,864
-444,971
| -73% | -$41.3M |
|
353
Texas Instruments
TXN
$182B
| $14.7M | 0.01% |
75,614
-38,738
| -34% | -$7.54M |
|
354
Atlantic Union Bankshares
AUB
$5.05B
| $14.6M | 0.01% |
443,150
+125,045
| +39% | +$4.11M |
|
355
Tourmaline Bio
TRML
$606M
| $14.5M | 0.01% |
1,127,691
+12,440
| +1% | +$160K |
|
356
XP
XP
$9.42B
| $14.5M | 0.01% |
821,991
-2,291,163
| -74% | -$40.3M |
|
357
IDEAYA Biosciences
IDYA
$2.23B
| $14.4M | 0.01% |
410,862
+154,613
| +60% | +$5.43M |
|
358
Twist Bioscience
TWST
$1.58B
| $14.4M | 0.01% |
291,495
+141,473
| +94% | +$6.97M |
|
359
Guardant Health
GH
$8.29B
| $14.4M | 0.01% |
497,088
+7,431
| +2% | +$215K |
|
360
Penumbra
PEN
$10.5B
| $13M | 0.01% |
72,464
-14,675
| -17% | -$2.64M |
|
361
Foot Locker
FL
$2.3B
| $12.9M | 0.01% |
+519,650
| New | +$12.9M |
|
362
Kymera Therapeutics
KYMR
$2.91B
| $12.8M | 0.01% |
429,287
+3,367
| +0.8% | +$101K |
|
363
Marcus & Millichap
MMI
$1.25B
| $12.7M | 0.01% |
401,530
+2,877
| +0.7% | +$90.7K |
|
364
Vertex
VERX
$3.98B
| $12.5M | 0.01% |
+345,357
| New | +$12.5M |
|
365
Structure Therapeutics
GPCR
$1.16B
| $12.4M | 0.01% |
+314,503
| New | +$12.4M |
|
366
BJs Wholesale Club
BJ
$13B
| $12.3M | 0.01% |
+140,155
| New | +$12.3M |
|
367
Insulet
PODD
$24.3B
| $12.3M | 0.01% |
60,787
-19,200
| -24% | -$3.87M |
|
368
Northern Oil and Gas
NOG
$2.61B
| $12.2M | 0.01% |
328,576
+132,518
| +68% | +$4.93M |
|
369
Freeport-McMoran
FCX
$64.5B
| $12M | 0.01% |
247,851
+745
| +0.3% | +$36.2K |
|
370
Apogee Therapeutics
APGE
$2.26B
| $12M | 0.01% |
306,078
+3,186
| +1% | +$125K |
|
|
MRX
371
Marex Group
MRX
$2.58B
| $11.9M | 0.01% |
+596,851
| New | +$11.9M |
|
372
RBC Bearings
RBC
$12.2B
| $11.8M | 0.01% |
43,766
+472
| +1% | +$127K |
|
373
Evolent Health
EVH
$1.11B
| $11.7M | 0.01% |
+611,816
| New | +$11.7M |
|
374
Nike
NKE
$110B
| $11.6M | 0.01% |
154,518
-8,705,062
| -98% | -$656M |
|
375
Corteva
CTVA
$50.2B
| $11.6M | 0.01% |
214,399
+197
| +0.1% | +$10.6K |
|